A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease.
paper
Cited
Public
Unavailable
- Authors
- Yanagisawa, Masahiro; Huveldt, Deborah; Kreinest, Pamela; Lohse, Christine M; Cheville, John C; Parker, Alexander S; Copland, John A; Anastasiadis, Panos Z
- Year
- 2008
- Journal
- The Journal of biological chemistry
- PMID
- 18407999
- DOI
- 10.1074/jbc.M801192200
- PMCID
- PMC2440599
p120 catenin is a cadherin-associated protein that regulates Rho GTPases and promotes the invasiveness of E-cadherin-deficient cancer cells. Multiple p120 isoforms are expressed in cells via alternative splicing, and all of them are essential for HGF signaling to Rac1. However, only full-length p120 (isoform 1) promotes invasiveness. This selective ability of p120 isoform 1 is mediated by reduced RhoA activity, both under basal conditions and following HGF treatment. All p120 isoforms can bind RhoA in vitro, via a central RhoA binding site. However, only the cooperative binding of RhoA to the central p120 domain and to the alternatively spliced p120 N terminus stabilizes RhoA binding and inhibits RhoA activity. Consistent with this, increased expression of p120 isoform 1, when compared with other p120 isoforms, is predictive of renal tumor micrometastasis and systemic progression, following nephrectomy. Furthermore, ectopic expression of the RhoA-binding, N-terminal domain of p120 is sufficient to block the ability of p120 isoform 1 to inhibit RhoA and to promote invasiveness. The data indicate that the increased expression of p120 isoform 1 during tumor progression contributes to the invasive phenotype of cadherin-deficient carcinomas and that the N-terminal domain of p120 is a valid therapeutic target.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. | 2025 | 40360802 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Alternative Splicing in Embryo Implantation. | Yu L et al. | β | 2025 | β |
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. | Strom NI et al. | β | 2025 | β |
| Proteogenomic Profiling of Treatment-NaΓ―ve Metastatic Malignant Melanoma. | Kuras M et al. | β | 2025 | β |
| Selecting differential splicing methods: Practical considerations for short-read RNA sequencing. | Draper BJ et al. | β | 2025 | β |
| A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype. | BartolomΓ© RA et al. | β | 2024 | β |
| A CRISPR-dCas13 RNA-editing tool to study alternative splicing. | NΓΊΓ±ez-Γlvarez Y et al. | β | 2024 | β |
| Alternative splicing in EMT and TGF-Ξ² signaling during cancer progression. | Zhang YE et al. | β | 2024 | β |
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder | Strom NI et al. | β | 2024 | β |
| Glioblastoma vaccines: past, present, and opportunities. | Xiong Z et al. | β | 2024 | β |
| Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment. | Lin WH et al. | β | 2023 | β |
| Chemoproteomic strategy identified p120-catenin glutathionylation regulates E-cadherin degradation and cell migration. | Kukulage DSK et al. | β | 2023 | β |
| p120-catenin subfamily members have distinct as well as shared effects on dendrite morphology during neuron development <i>in vitro</i>. | Donta MS et al. | β | 2023 | β |
| Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics. | Li L et al. | β | 2023 | β |
| SNORA73B promotes endometrial cancer progression through targeting MIB1 and regulating host gene RCC1 alternative splicing. | Chen X et al. | β | 2023 | β |
| The genomic regulation of metastatic dormancy. | Gelman IH | β | 2023 | β |
| Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. | Huang Z et al. | β | 2022 | β |
| ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer. | Lee J et al. | β | 2022 | β |
| Histone marks regulate the epithelial-to-mesenchymal transition via alternative splicing. | Segelle A et al. | β | 2022 | β |
| <i>DJExpress</i>: An Integrated Application for Differential Splicing Analysis and Visualization. | Gallego-Paez LM et al. | β | 2022 | β |
| Knowledge mapping of alternative splicing of cancer from 2012 to 2021: A bibliometric analysis. | Tian B et al. | β | 2022 | β |
| Regulation of Alternative Splicing during Epithelial-Mesenchymal Transition. | Lyu J et al. | β | 2022 | β |
| The global Protein-RNA interaction map of ESRP1 defines a post-transcriptional program that is essential for epithelial cell function. | Peart NJ et al. | β | 2022 | β |
| Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators? | Migault M et al. | β | 2022 | β |
| Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy. | Mehterov N et al. | β | 2021 | β |
| Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance. | Roy Burman D et al. | β | 2021 | β |
| APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells. | Faux MC et al. | β | 2021 | β |
| Bioinformatic approaches to the investigation of the atavistic genes implicated in cancer. | Louka A et al. | β | 2021 | β |
| Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma. | Lai J et al. | β | 2021 | β |
| The Cross-Talk Between EGFR and E-Cadherin. | RamΓrez Moreno M et al. | β | 2021 | β |
| An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin. | Wu Y et al. | β | 2020 | β |
| Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures. | Wang Y et al. | β | 2020 | β |
| Intratumor Ξ΄-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression. | Li M et al. | β | 2020 | β |
| Modulator-Dependent RBPs Changes Alternative Splicing Outcomes in Kidney Cancer. | Wang Y et al. | β | 2020 | β |
| Monoubiquitination of p120-catenin is essential for TGFΞ²-induced epithelial-mesenchymal transition and tumor metastasis. | Wu Q et al. | β | 2020 | β |
| P120 and E-cadherin: Double-edged swords in tumor metastasis. | Venhuizen JH et al. | β | 2020 | β |
| The multifarious regulation of the apical junctional complex. | Rusu AD et al. | β | 2020 | β |
| The Regulation of Intestinal Mucosal Barrier by Myosin Light Chain Kinase/Rho Kinases. | Jin Y et al. | β | 2020 | β |
| Cadmium and Lead Decrease Cell-Cell Aggregation and Increase Migration and Invasion in Renca Mouse Renal Cell Carcinoma Cells. | Akin R et al. | β | 2019 | β |
| Differential expression of p120-catenin 1 and 3 isoforms in epithelial tissues. | Venhuizen JH et al. | β | 2019 | β |
| Expression of ZNF695 Transcript Variants in Childhood B-Cell Acute Lymphoblastic Leukemia. | Rosa R et al. | β | 2019 | β |
| P120 catenin expression and its correlation with E-cadherin in salivary gland neoplasms. | Phattarataratip E et al. | β | 2019 | β |
| P120 Catenin Isoforms Differentially Associate with Breast Cancer Invasion and Metastasis. | Venhuizen JH et al. | β | 2019 | β |
| Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma. | Hamilton MJ et al. | β | 2018 | β |
| p120-catenin is required for regulating epidermal proliferation, differentiation, and barrier function. | Xie Z et al. | β | 2018 | β |
| A central role for cadherin signaling in cancer. | Kourtidis A et al. | β | 2017 | β |
| Cell-specific diversity in the expression and organization of cytoplasmic plaque proteins of apical junctions. | Vasileva E et al. | β | 2017 | β |
| Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1. | Liao XH et al. | β | 2017 | β |
| EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression. | Pradella D et al. | β | 2017 | β |
| Mib1 contributes to persistent directional cell migration by regulating the Ctnnd1-Rac1 pathway. | Mizoguchi T et al. | β | 2017 | β |
| p120-catenin in canonical Wnt signaling. | DuΓ±ach M et al. | β | 2017 | β |
| Progression of Human Renal Cell Carcinoma via Inhibition of RhoA-ROCK Axis by PARG1. | Miyazaki J et al. | β | 2017 | β |
| Rho GTPases and actomyosin: Partners in regulating epithelial cell-cell junction structure and function. | Arnold TR et al. | β | 2017 | β |
| RORΞ±2 requires LSD1 to enhance tumor progression in breast cancer. | Kim K et al. | β | 2017 | β |
| The Functional Impact of Alternative Splicing in Cancer. | Climente-GonzΓ‘lez H et al. | β | 2017 | β |
| Beyond Ξ²-catenin: prospects for a larger catenin network in the nucleus. | McCrea PD et al. | β | 2016 | β |
| Cigarette smoke extract-induced p120-mediated NF-ΞΊB activation in human epithelial cells is dependent on the RhoA/ROCK pathway. | Zhang C et al. | β | 2016 | β |
| p120-catenin controls contractility along the vertical axis of epithelial lateral membranes. | Yu HH et al. | β | 2016 | β |
| p120 Catenin-Mediated Stabilization of E-Cadherin Is Essential for Primitive Endoderm Specification. | Pieters T et al. | β | 2016 | β |
| p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis. | van de Ven RA et al. | β | 2016 | β |
| Phosphorylation and isoform use in p120-catenin during development and tumorigenesis. | Hong JY et al. | β | 2016 | β |
| Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition. | GΓΆttgens EL et al. | β | 2016 | β |
| The Genome-Wide Analysis of Carcinoembryonic Antigen Signaling by Colorectal Cancer Cells Using RNA Sequencing. | Bajenova O et al. | β | 2016 | β |
| Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer. | SebestyΓ©n E et al. | β | 2015 | β |
| Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer. | Kourtidis A et al. | β | 2015 | β |
| The Expression of the Zonula Adhaerens Protein PLEKHA7 Is Strongly Decreased in High Grade Ductal and Lobular Breast Carcinomas. | Tille JC et al. | β | 2015 | β |
| The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. | Okada T et al. | β | 2015 | β |
| DIPA-family coiled-coils bind conserved isoform-specific head domain of p120-catenin family: potential roles in hydrocephalus and heterotopia. | Markham NO et al. | β | 2014 | β |
| Genome-wide activities of RNA binding proteins that regulate cellular changes in the epithelial to mesenchymal transition (EMT). | Bebee TW et al. | β | 2014 | β |
| Molecular mechanisms of epithelial-mesenchymal transition. | Lamouille S et al. | β | 2014 | β |
| Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease. | Knowles BC et al. | β | 2014 | β |
| PTP-PEST targets a novel tyrosine site in p120 catenin to control epithelial cell motility and Rho GTPase activity. | Espejo R et al. | β | 2014 | β |
| RhoGTPases, actomyosin signaling and regulation of the epithelial Apical Junctional Complex. | Quiros M et al. | β | 2014 | β |
| Beta-catenin versus the other armadillo catenins: assessing our current view of canonical Wnt signaling. | Miller RK et al. | β | 2013 | β |
| Concomitant loss of p120-catenin and Ξ²-catenin membrane expression and oral carcinoma progression with E-cadherin reduction. | Sasaya K et al. | β | 2013 | β |
| Cyclin-dependent kinase 5 promotes the stability of corneal epithelial cell junctions. | Arpitha P et al. | β | 2013 | β |
| Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds. | Samatov TR et al. | β | 2013 | β |
| Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion. | Lu H et al. | β | 2013 | β |
| Interaction of p190RhoGAP with C-terminal domain of p120-catenin modulates endothelial cytoskeleton and permeability. | Zebda N et al. | β | 2013 | β |
| Neural Wiskott-Aldrich syndrome protein (N-WASP)-mediated p120-catenin interaction with Arp2-Actin complex stabilizes endothelial adherens junctions. | Rajput C et al. | β | 2013 | β |
| Overexpression of small GTPases directly correlates with expression of Ξ΄-catenin and their coexpression predicts a poor clinical outcome in nonsmall cell lung cancer. | Zhang JY et al. | β | 2013 | β |
| p120catenin alteration in cancer and its role in tumour invasion. | Peglion F et al. | β | 2013 | β |
| p120 catenin: an essential regulator of cadherin stability, adhesion-induced signaling, and cancer progression. | Kourtidis A et al. | β | 2013 | β |
| Phosphorylation-mediated 14-3-3 protein binding regulates the function of the rho-specific guanine nucleotide exchange factor (RhoGEF) Syx. | Ngok SP et al. | β | 2013 | β |
| Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition. | Aparicio LA et al. | β | 2013 | β |
| RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. | Venables JP et al. | β | 2013 | β |
| Regulatory networks defining EMT during cancer initiation and progression. | De Craene B et al. | β | 2013 | β |
| RhoA is down-regulated at cell-cell contacts via p190RhoGAP-B in response to tensional homeostasis. | Ponik SM et al. | β | 2013 | β |
| Association of Rho-associated protein kinase 1 with E-cadherin complexes is mediated by p120-catenin. | Smith AL et al. | β | 2012 | β |
| Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). | Warzecha CC et al. | β | 2012 | β |
| Effect of p120 catenin silencing on biological behaviors of PANC-1 cells. | Cheng Z et al. | β | 2012 | β |
| Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing. | Dittmar KA et al. | β | 2012 | β |
| Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT). | Biamonti G et al. | β | 2012 | β |
| N-cadherin expression level as a critical indicator of invasion in non-epithelial tumors. | PΓ©glion F et al. | β | 2012 | β |
| N-terminal 1-54 amino acid sequence and Armadillo repeat domain are indispensable for P120-catenin isoform 1A in regulating E-cadherin. | Yu J et al. | β | 2012 | β |
| p120-Catenin: a novel regulator of innate immunity and inflammation. | Hu G | β | 2012 | β |
| Regulation of adherens junctions by Rho GTPases and p120-catenin. | Menke A et al. | β | 2012 | β |
| Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients. | Armakolas A et al. | β | 2012 | β |
| The three-dimensional structure of the cadherin-catenin complex. | Ishiyama N et al. | β | 2012 | β |
| Upon Wnt stimulation, Rac1 activation requires Rac1 and Vav2 binding to p120-catenin. | Valls G et al. | β | 2012 | β |
| Involvement of the TGF-beta and beta-catenin pathways in pelvic lymph node metastasis in early-stage cervical cancer. | Noordhuis MG et al. | β | 2011 | β |
| p120 catenin is required for normal renal tubulogenesis and glomerulogenesis. | Marciano DK et al. | β | 2011 | β |
| p120 regulates endothelial permeability independently of its NH2 terminus and Rho binding. | Herron CR et al. | β | 2011 | β |
| Regulation of small GTPases at epithelial cell-cell junctions. | Citi S et al. | β | 2011 | β |
| Slug (SNAI2) expression in oral SCC cells results in altered cell-cell adhesion and increased motility. | Katafiasz D et al. | β | 2011 | β |
| Wnt controls the transcriptional activity of Kaiso through CK1Ξ΅-dependent phosphorylation of p120-catenin. | Del Valle-PΓ©rez B et al. | β | 2011 | β |
| Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. | Slorach EM et al. | β | 2011 | β |
| Ξ±-Catenin contributes to the strength of E-cadherin-p120 interactions. | Troyanovsky RB et al. | β | 2011 | β |
| Altered expression of p120catenin predicts poor outcome in invasive breast cancer. | Talvinen K et al. | β | 2010 | β |
| An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. | Warzecha CC et al. | β | 2010 | β |
| A p120-catenin-CK1epsilon complex regulates Wnt signaling. | Casagolda D et al. | β | 2010 | β |
| Downregulation of HDPR1 is associated with poor prognosis and affects expression levels of p120-catenin and beta-catenin in nonsmall cell lung cancer. | Yang ZQ et al. | β | 2010 | β |
| Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion. | Ishiyama N et al. | β | 2010 | β |
| HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. | Johnson E et al. | β | 2010 | β |
| Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. | Yori JL et al. | β | 2010 | β |
| p120-Catenin is required for mouse vascular development. | Oas RG et al. | β | 2010 | β |
| p120ctn isoform 1 expression significantly correlates with abnormal expression of E-cadherin and poor survival of lung cancer patients. | Miao Y et al. | β | 2010 | β |
| Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members. | Hong JY et al. | β | 2010 | β |
| The 19-amino acid insertion in the tumor-associated splice isoform Rac1b confers specific binding to p120 catenin. | Orlichenko L et al. | β | 2010 | β |
| The catenin family at a glance. | McCrea PD et al. | β | 2010 | β |
| The Misregulation of Cell Adhesion Components during Tumorigenesis: Overview and Commentary. | Andl CD | β | 2010 | β |
| The molecular evolution of the p120-catenin subfamily and its functional associations. | Carnahan RH et al. | β | 2010 | β |
| An acidic extracellular pH disrupts adherens junctions in HepG2 cells by Src kinases-dependent modification of E-cadherin. | Chen Y et al. | β | 2009 | β |
| Cadherin and integrin regulation of epithelial cell migration. | Silvestre J et al. | β | 2009 | β |
| Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses. | Strauss R et al. | β | 2009 | β |
| ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. | Warzecha CC et al. | β | 2009 | β |
| Fibroblast activation and myofibroblast generation in obstructive nephropathy. | Grande MT et al. | β | 2009 | β |
| p120-catenin inhibits VE-cadherin internalization through a Rho-independent mechanism. | Chiasson CM et al. | β | 2009 | β |
| P120-catenin isoforms 1A and 3A differently affect invasion and proliferation of lung cancer cells. | Liu Y et al. | β | 2009 | β |
| PDGF receptor activation induces p120-catenin phosphorylation at serine 879 via a PKCalpha-dependent pathway. | Brown MV et al. | β | 2009 | β |
| The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. | Warzecha CC et al. | β | 2009 | β |
| Cadherins and cancer: how does cadherin dysfunction promote tumor progression? | Jeanes A et al. | β | 2008 | β |
| Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer. | Perez-Moreno M et al. | β | 2008 | β |
| p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression. | Soto E et al. | β | 2008 | β |
| Synapses are regulated by the cytoplasmic tyrosine kinase Fer in a pathway mediated by p120catenin, Fer, SHP-2, and beta-catenin. | Lee SH et al. | β | 2008 | β |